Study guide
11.2 Core Midwifery Medicines Administration & Controlled Drugs Storage/Recording
NMC Test of Competence Part 1: Midwifery Computer-Based Test Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: NMC Framework, Autonomy & Professional Ethics
1.1 NMC Regulatory Architecture, RM Registration & The Code 1.2 Autonomous Midwifery Practice, Accountability & Delegation 1.3 Informed Consent, Capacity, Advocacy & Human Rights 1.4 Duty of Candour, Confidentiality & Clinical Documentation Human Rights, Equality, Anti-Discriminatory & Culturally Sensitive Care
2 Chapter 2: Continuity, Public Health & Perinatal Mental Health
2.1 Continuity of Carer & Physiological Midwifery Care 2.2 Public Health, Social Determinants & Health Inequalities 2.3 Perinatal Mental Health Assessment & Emergency Psychiatric Care UK Health & Social Care System, Birth Settings, Safe Staffing & Keeping Mothers and Babies Together
3 Chapter 3: Safeguarding, Vulnerable Populations & FGM
3.1 Safeguarding Children & Adults at Risk in Maternity Care 3.2 Domestic Abuse Identification, Risk Assessment & Multi-Agency Referral 3.3 FGM Mandatory Reporting, Clinical Classification & Trauma-Informed Practice
4 Chapter 4: Universal Antenatal Care & Fetal Assessment
4.1 Antenatal Care Schedule, Physiological Adaptations & Routine Investigations 4.2 Fetal Growth Surveillance, Fundal Height & Symphysis-Fundal Height (SFH) Plotting 4.3 UK National Screening Committee (UK NSC) Antenatal Screening Programmes 4.4 Antenatal Education, Birth Planning & Minor Disorders of Pregnancy Reproductive Anatomy, Genetics & Genomics, Embryology and Fetal Development
5 Chapter 5: Universal Intrapartum Care & Physiological Labour
5.1 Physiology of Normal Labour, Hormonal Regulation & Latent vs Active First Stage 5.2 Second Stage Management, Mechanisms of Normal Labour & Perineal Protection 5.3 Third Stage Management: Active vs Physiological & Examination of Placenta/Membranes 5.4 Pain Management in Labour: Non-Pharmacological & Pharmacological Analgesia
6 Chapter 6: Universal Postnatal Care & Infant Feeding
6.1 Physiological Maternal Postnatal Involution, Assessment & Recovery 6.2 Perineal Trauma Assessment, Classification (1st to 4th Degree) & Care Principles 6.3 Physiology of Lactation, Breastfeeding Support & UNICEF Baby Friendly Standards 6.4 Formula Feeding Safety, Responsive Bottle Feeding & Infant Growth Patterns Contraception & Sexual and Reproductive Health after Birth
7 Chapter 7: Newborn Assessment & Neonatal Care
7.1 Newborn Transition, Apgar Scoring, Thermoregulation & Skin-to-Skin Care 7.2 Newborn Physical Examination (NIPE 4 Core Elements) & Routine Prophylaxis 7.3 Neonatal Blood Spot Screening, Hearing Screening & Infection Prevention
8 Chapter 8: Medical & Obstetric Antenatal Complications
8.1 Pre-existing Medical Conditions in Pregnancy (Diabetes, Cardiac, Epilepsy, Renal) 8.2 Hypertensive Disorders of Pregnancy, Pre-eclampsia & Eclampsia 8.3 Antepartum Haemorrhage: Placenta Praevia, Placental Abruption & Vasa Praevia 8.4 Gestational Diabetes Mellitus (GDM): Screening, Diagnostic Criteria & Management
9 Chapter 9: Intrapartum Complications & Obstetric Emergencies
9.1 Postpartum Haemorrhage (PPH): Definition, 4Ts, Bimanual Compression & Medical Protocols 9.2 Shoulder Dystocia: Recognition, Risk Factors & HELPERR Emergency Sequence 9.3 Umbilical Cord Prolapse, Uterine Rupture & Amniotic Fluid Embolism 9.4 Maternal Sepsis, MEOWS Escalation & Maternal Resuscitation (Modified BLS/ALS)
10 Chapter 10: Fetal Compromise & Neonatal Complications
10.1 Intrapartum Fetal Heart Rate Monitoring & CTG Interpretation (NICE / FIGO) 10.2 Neonatal Resuscitation: Resuscitation Council UK NLS Algorithm 10.3 Neonatal Hypoglycaemia, Hyperbilirubinaemia & Neonatal Sepsis (NICE NG195) 10.4 Perinatal Loss, Bereavement Care & Perinatal Palliative Support
11 Chapter 11: Midwifery Pharmacology, Prescribing & Skills
11.1 Midwives Exemptions under Human Medicines Regulations 2012 & PGDs 11.2 Core Midwifery Medicines Administration & Controlled Drugs Storage/Recording 11.3 Episiotomy: Clinical Indications, Infiltration Technique & Incision Anatomy 11.4 Aseptic Non-Touch Technique (ANTT), Bladder Catheterisation & Cannulation Infection Prevention & Control, Communicable Disease Surveillance and Antimicrobial Stewardship
12 Chapter 12: Leadership, Multidisciplinary Safety & Quality
12.1 Interprofessional Team Communication, SBAR Handover & Human Factors 12.2 Incident Reporting, Root Cause Analysis & Learning from Reviews (MNSI, MBRRACE) 12.3 Midwife as Scholar, Clinical Supervisor, Leader & Escalating Safety Concerns Research Methods, Critical Appraisal, Audit & Service Evaluation Quality Improvement, Change Management, Sustainable Healthcare & Digital Practice Resilience, Wellbeing, Reflection, Human Factors & Leading Care
13 Chapter 13: Part A Numeracy & Drug Calculation Mastery
13.1 Metric Units, Conversions, Rounding & CBT Pearson VUE Numeric Answer Rules 13.2 Oral Medications, Liquid Suspensions & Solid Dose Calculations 13.3 Injectable Medicines, Dilutions, Percentages & Weight-Based Calculations 13.4 Intravenous Infusions, Flow Rates, Syntocinon/Oxytocin & Magnesium Sulfate Protocols
11.2 Core Midwifery Medicines Administration & Controlled Drugs Storage/Recording
Key Takeaways Explain This Topic AI
The NMC withdrew its Standards for Medicines Management in 2019; midwives now follow the Code and RPS/RCN administration guidance, using checks such as the '6 Rights'.
Under the Misuse of Drugs Act 1971 and 2001 Regulations, Schedule 2 Controlled Drugs (diamorphine, morphine, pethidine) mandate storage in a double-locked steel cupboard and independent dual-practitioner checks for dispensing, administration, and destruction.
The Controlled Drugs Register (CDR) must be a dedicated bound book with numbered pages (or compliant electronic register) where every receipt, administration, and witnessed discard is recorded chronologically without erasures or correction fluid.
Any Controlled Drug stock discrepancy between physical counts and register balances must be investigated immediately and reported without delay to the Ward Manager, Pharmacy, and the Controlled Drugs Accountable Officer (CDAO).
Fridge-stored maternity medicines and vaccines are kept between 2°C and 8°C, with current, minimum and maximum temperatures recorded at least daily.
Last updated: October 2026
Core Midwifery Medicines Administration & Controlled Drugs Storage/Recording
Safe and proficient medicines management is a foundational pillar of modern professional midwifery. Midwives bear personal professional accountability for every medication they prepare, dispense, administer, or withhold. In the maternity setting, where pharmacotherapy impacts both the mother and the developing fetus or newborn infant, strict compliance with the NMC Code (2015, updated 2018) , the Misuse of Drugs Act 1971 , and the Misuse of Drugs Regulations 2001 is paramount to prevent adverse drug events, uphold statutory law, and preserve public safety.
The NMC Professional Standards & The "6 Rights" of Administration
The Nursing and Midwifery Council sets explicit expectations regarding registrant accountability in medicines management. The Code emphasizes that registered midwives must:
Work within their sphere of clinical competence, recognizing when to seek expert guidance.
Maintain clear, contemporaneous, and legible documentation of all pharmacological interventions.
Ensure informed consent is obtained prior to administering any medicinal substance.
Assess the therapeutic response and promptly report any unexpected adverse reactions or errors.
The Core "6 Rights" of Medication Administration
To eliminate preventable administration errors, midwives must systematically execute the 6 Rights prior to administering any substance:
Right Woman or Baby : Positively verify the identity of the recipient using two unique identifiers: full legal name, date of birth, and unique hospital/NHS number. In hospital settings, cross-check the patient's identity wristband against the prescription chart. In community settings, verbally confirm identity details with the woman. When administering medicines to a neonate, verify the baby's identity band attached to the limb against maternal records.
Right Medicine : Read the prescription order carefully. Cross-check the generic name, trade name, and formulation on the drug packaging against the prescription chart on three separate occasions: when removing the medicine from storage, during preparation/drawing up, and immediately prior to administration at the bedside. Verify that the medication is not expired.
Right Dose : Independently perform all dosage calculations. Confirm that the prescribed dose aligns with standard British National Formulary (BNF) or BNF for Children recommendations, maternal weight, gestational age, and renal/hepatic parameters. Inspect the volume and concentration to ensure accurate measurement.
Right Route : Administer the medication strictly via the authorized anatomical route (e.g., oral, sublingual, subcutaneous, intramuscular, intravenous infusion, or rectal). Confirm that the formulation is specifically manufactured and licensed for that designated route (e.g., ensuring an intramuscular formulation is never injected intravenously).
Right Time : Verify the prescribed administration time, dosing interval, and clinical timing relative to physiological events (e.g., administering prophylactic oxytocin immediately following the delivery of the anterior shoulder or full birth of the infant during the third stage of labour).
Right Documentation : Document the administration immediately after the drug is given, never beforehand. Record the exact date, time, dosage, route, site of injection, batch number, expiry date, and the legible signature or electronic credential of the administering practitioner.
Essential Expanded Rights in Midwifery Practice
Beyond the traditional six rights, contemporary clinical governance encompasses critical supplementary dimensions:
Right to Refuse : Midwives must respect maternal autonomy. A competent pregnant or postnatal woman has the absolute legal and ethical right to decline any medication after being fully informed of the risks and benefits. When a woman refuses, the midwife must explore her concerns, document the refusal comprehensively in the maternal records, notify the multidisciplinary team, and institute alternative care plans.
Right Reason / Indication : The midwife must understand the explicit clinical rationale for the medication and confirm that the drug is clinically appropriate for the woman's current clinical status.
Right Response / Evaluation : The midwife must continuously evaluate the woman and fetus for desired therapeutic effects and monitor for recognized adverse reactions (e.g., monitoring maternal blood pressure after labetalol or fetal heart rate following opioid analgesia).
Controlled Drugs (CDs) Governance in Maternity Care
Controlled Drugs are substances subject to high levels of regulation due to their potential for misuse, dependence, and diversion. In the UK, their management is governed by the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001 (as amended).
Classification and Schedules
The 2001 Regulations divide Controlled Drugs into five distinct schedules based on their therapeutic utility and risk of harm. Maternity care primarily utilizes:
Schedule 2 Controlled Drugs : High therapeutic utility but significant abuse potential. Includes potent opioids: Diamorphine , Morphine , Pethidine , and Fentanyl . Subject to the strictest statutory storage, register-recording, dual-checking, and destruction mandates.
Schedule 3 Controlled Drugs : Includes barbiturates and certain intermediate-acting substances (e.g., Midazolam , Temazepam ). Subject to safe custody storage requirements, but exempt from formal bound CD register entries in standard ward administration (though local hospital policies often mandate registration).
Schedule 4 & 5 Controlled Drugs : Benzodiazepines (Schedule 4 Part 1) and dilute preparations of opioids such as low-strength codeine (Schedule 5); subject to standard prescription-only medicine storage.
Safe Storage & Physical Security
Under the Misuse of Drugs (Safe Custody) Regulations 1973 , Schedule 2 Controlled Drugs must be stored securely to prevent unauthorized access:
Dedicated Steel Cupboard : Must be constructed of heavy-gauge sheet steel, securely bolted to a solid brick or concrete wall, or secured to a solid floor with heavy-duty rag bolts.
Double-Lock System : The CD cupboard must feature a robust double-lock mechanism. In traditional settings, this requires two distinct physical keys held on a designated key ring. In modern facilities, electronic biometric or electronic key-fob systems provide an automated electronic audit trail.
Key Custody : The keys to the Controlled Drugs cupboard must be retained in the personal custody of a designated Registered Midwife or Nurse (the 'Nurse-in-Charge' or designated delivery suite coordinator). The keys must never be left unattended, placed in open drawers, or handed to student midwives or unregistered personnel.
Exclusive Storage : The CD cupboard must contain only Controlled Drugs. Non-controlled pharmaceuticals, patient valuables, cash, or routine ward items must never be stored inside.
The Controlled Drugs Register (CDR)
Every clinical ward, birth centre, or delivery suite holding Schedule 2 drugs must maintain a formal Controlled Drugs Register (CDR) in accordance with Regulation 19 of the Misuse of Drugs Regulations 2001:
Bound Book with Numbered Pages : The physical register must be a permanently bound volume with pre-printed, sequential page numbering to prevent page removal. Alternatively, the Misuse of Drugs Regulations allow computerised registers, provided entries are attributable to the person making them, cannot be altered without an audit trail, and can be produced for inspection.
Separate Folios : A dedicated, separate page or section must be allocated for each drug, each pharmaceutical formulation, and each specific strength (e.g., separate folios for Diamorphine 5 mg ampoules and Diamorphine 10 mg ampoules).
Strict Legibility & Prohibited Erasures : All entries must be written in indelible ink. The use of correction fluid (Tipp-Ex), erasures, scraping, or overwriting is strictly illegal . If an error is made, the midwife must draw a single neat line through the erroneous entry, write the correction clearly in the margin, and initial and date the alteration.
Required Entry Fields : Every transaction (receipt from pharmacy, administration to a patient, or return) must be logged chronologically and include:
Date and exact time of transaction.
Full name of the woman to whom the drug was administered.
Hospital number or unique patient identifier.
Exact dose administered.
Name, designation, and signature of the administering Registered Midwife.
Name, designation, and signature of the witnessing practitioner.
Resulting running balance of physical stock remaining in the cupboard.
Dual-Practitioner Independent Checking & Waste Disposal
To ensure absolute safety, the administration of Schedule 2 Controlled Drugs requires two-practitioner independent checking at every stage of the process: ┌─────────────────────────────────────────────────────────────────┐
- │ INDEPENDENT CHECKING STEP 1 │
- │ Midwife 1 & Midwife 2 independently verify prescription chart: │
- │ Patient Name, Drug, Dose, Route, Time, Frequency │
- └────────────────────────────────┬────────────────────────────────┘
- │
- ▼
- ┌─────────────────────────────────────────────────────────────────┐
- │ INDEPENDENT CHECKING STEP 2 │
- │ At CD Cupboard: Verify physical ampoules, concentration, │
- │ expiry date, calculate volume, and physically count balance │
- └────────────────────────────────┬────────────────────────────────┘
- │
- ▼
- ┌─────────────────────────────────────────────────────────────────┐
- │ INDEPENDENT CHECKING STEP 3 │
- │ Prepare and draw up drug in presence of witness. Sign register: │
- │ Administering Midwife + Witnessing Professional sign entry │
- └────────────────────────────────┬────────────────────────────────┘
- │
- ▼
- ┌─────────────────────────────────────────────────────────────────┐
- │ INDEPENDENT CHECKING STEP 4 │
- │ At Bedside: Check maternal identity wristband, allergy band, │
- │ witness physical administration, discard waste, document chart │
- └─────────────────────────────────────────────────────────────────┘
- Destruction and Disposal of Controlled Drug Waste
In clinical maternity practice, a woman may require only a fraction of an ampoule (for example, administering 5 mg of diamorphine prepared from a 10 mg ampoule). Under the Misuse of Drugs Regulations 2001:
Immediate Destruction : The remaining surplus drug (5 mg) must be destroyed immediately at the time of preparation and rendered completely irretrievable.
Denaturing Protocol : The surplus liquid must be expelled into an approved pharmaceutical waste absorption bin or a dedicated Controlled Drugs denaturing kit (containing absorbent granules), never squirted onto cotton wool or poured directly into clinical sinks.
Witnessed Disposal : The destruction of residual waste must be directly witnessed by the second practitioner.
Register Recording : The CDR entry must explicitly record the total amount taken from stock (10 mg), the dose administered (5 mg), and the quantity destroyed/wasted (5 mg), witnessed and countersigned by both practitioners.
Discrepancy Escalation & The Controlled Drugs Accountable Officer (CDAO)
A physical stock count of every Controlled Drug must be performed at least once every 24 hours (and typically at every change of nursing/midwifery shift) by two registered practitioners.
If the physical count does not match the running balance in the CDR:
Immediate Audit : Re-check all recent arithmetic calculations, examine all administration entries over the preceding 24–48 hours, and inspect the CD cupboard to ensure no ampoules have rolled behind shelving.
Immediate Local Escalation : If the discrepancy remains unresolved, notify the Delivery Suite Coordinator, Ward Manager, and Lead Clinical Pharmacist immediately.
Formal Statutory Reporting : The unresolved discrepancy must be formally escalated to the Controlled Drugs Accountable Officer (CDAO) of the healthcare organization. Under the Health Act 2006 (Controlled Drugs (Supervision of Management and Use) Regulations 2013) , every NHS Trust and healthcare organization must appoint a CDAO with statutory responsibility for overseeing the safe custody, investigating thefts or losses, and liaising with the police and regulatory authorities where criminal diversion is suspected.
Pharmacology in Pregnancy, Birth and Breastfeeding
The Future Midwife standards (3.18) expect midwives to understand pharmacology and to recognise the positive and adverse effects of medicines across the continuum of care, including allergies, sensitivities, side effects, contraindications, incompatibilities, adverse reactions, prescribing errors, polypharmacy and over-the-counter medicines.
How Pregnancy Changes Drug Handling
Absorption : Nausea, vomiting and slower gastric emptying in pregnancy and labour can delay or reduce absorption of oral medicines (opioids slow gastric emptying further).
Distribution : Plasma volume rises by about 40% to 50% and albumin falls, so water-soluble drugs are diluted and more of a highly protein-bound drug may be unbound.
Metabolism : Hepatic enzyme activity changes; for example, oestrogen increases glucuronidation, which lowers lamotrigine levels.
Excretion : Renal blood flow and glomerular filtration rise by about 50%, increasing clearance of renally excreted drugs such as lithium and some antibiotics.
Placental Transfer : Small, lipid-soluble, unionised and non-protein-bound drugs cross the placenta most readily. Opioids cross easily, which is why neonatal respiratory depression can follow pethidine or diamorphine given close to birth.
Breastfeeding : Most medicines are compatible with breastfeeding. Transfer into milk depends on the drug's protein binding, lipid solubility and half-life, and the baby's age and maturity. Midwives check resources such as the BNF and specialist breastfeeding drug information services, and avoid advising women to stop breastfeeding without good reason.
Adverse Drug Reactions, Allergies and Contraindications
Allergy Checks : Confirm the woman's allergy status and the nature of any previous reaction before every first dose. A true allergy (for example, anaphylaxis to penicillin) differs from a side effect (for example, nausea).
Side Effects and Adverse Reactions : Examples include hypotension with rapid IV oxytocin, vomiting and hypertension with ergometrine, bronchospasm with carboprost, and respiratory depression with opioids.
Contraindications and Cautions : Ergometrine is contraindicated in hypertension and pre-eclampsia; NSAIDs such as diclofenac are avoided in severe pre-eclampsia, renal impairment, asthma sensitive to NSAIDs and significant haemorrhage.
Incompatibilities : Some drugs must not be mixed in the same line or syringe; check the product information and local IV guidance before giving drugs together.
Reporting : Suspected adverse drug reactions are reported through the MHRA Yellow Card scheme. Reporting is especially valuable in pregnancy and breastfeeding, where trial data are limited.
Polypharmacy, Over-the-Counter Medicines and Errors
Polypharmacy : Women with long-term conditions may take several medicines (for example, antiepileptics, antihypertensives, antidepressants and anticoagulants). Each new medicine increases the risk of interactions, so a full medicines reconciliation is completed at booking, admission and transfer.
Over-the-Counter and Herbal Products : Ask specifically about non-prescription medicines, herbal remedies and supplements. For example, high-dose vitamin A (retinol) supplements and fish liver oil are avoided in pregnancy, and some herbal products interact with prescribed medicines.
Prescribing and Administration Errors : If a prescription is unclear, illegible or appears wrong, the midwife must not administer it and must contact the prescriber. Any error or near miss is reported through local incident systems, and the duty of candour applies if harm results.
Medication Error Reporting & The Statutory Duty of Candour
When a medicines administration error occurs (e.g., incorrect dose administered, omitted dose, or wrong patient), the midwife must act immediately with professional integrity and transparency.
Immediate Clinical Actions
Patient Safety Assessment : Immediately assess the maternal and fetal/neonatal clinical condition. Obtain vital signs and initiate supportive care or specific reversal agents (such as naloxone) if toxicity is present.
Medical Escalation : Inform the attending obstetrician and neonatal team immediately.
Clinical Incident Logging : Submit an electronic incident report via the organization's risk management system (e.g., Datix , Ulysses , or the national Learn from Patient Safety Events [LFPSE] service) within 24 hours.
The Duty of Candour
Under Regulation 20 of the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 and the NMC Code, midwives have a legal and professional Duty of Candour :
When an unintended or unexpected incident occurs that results in moderate harm, severe harm, or psychological distress, the midwife and healthcare team must inform the woman and her family promptly.
Provide an open, honest, and compassionate verbal explanation of what occurred.
Offer a sincere, formal apology on behalf of the healthcare team.
Document the discussion in the healthcare records and provide written follow-up outlining the investigation findings and measures instituted to prevent recurrence.
Cold Chain Integrity & Storage of Thermosensitive Medicines
Many essential maternity medications are highly sensitive to thermal degradation. Maintaining an uninterrupted cold chain between 2°C and 8°C is essential to ensure that pharmaceuticals retain their potency and clinical efficacy.
Thermosensitive Maternity Medicine Storage Requirement Clinical Risk of Cold Chain Breach
Oxytocin (Syntocinon) 2°C to 8°C (protect from light) Rapid thermal denaturation; loss of uterotonic potency leading to failure of third-stage prophylaxis and catastrophic uncontrolled PPH.
Ergometrine Maleate / Syntometrine 2°C to 8°C (protect from light) Photolytic and thermal degradation; diminished smooth muscle contractile efficacy during obstetric haemorrhage.
Dinoprostone Vaginal Gel (Prostin E2) 2°C to 8°C (refrigerated) Loss of prostaglandin activity; ineffective cervical ripening for induction of labour.
Dinoprostone Vaginal Insert (Propess) -10°C to -25°C (freezer storage) Must remain frozen until immediately prior to insertion; premature thawing compromises drug reservoir release kinetics.
Hepatitis B & BCG Vaccines 2°C to 8°C (do not freeze) Freezing destroys vaccine adjuvant emulsions; heat exposure denatures antigens, causing immunological failure in neonatal immunization.
Daily Monitoring & Protocol for Cold Chain Breaches
Daily Logging : Refrigerator temperatures must be monitored using calibrated digital minimum/maximum thermometers. Registrants must record the current, minimum, and maximum temperatures daily, subsequently resetting the thermometer.
Action in Breaches : If temperatures fall below 2°C or rise above 8°C, the midwife must immediately:
Quarantine all affected stock within the refrigerator and affix a prominent label: "DO NOT USE – QUARANTINED STOCK DUE TO TEMPERATURE EXCURSION" .
Log the exact temperature range and estimated duration of the breach.
Contact the hospital pharmacy department to obtain stability data or arrange replacement stock.
Never administer potentially compromised medicines to women or neonates.